FDA Approves Esketamine as First Monotherapy for Treatment-Resistant Depression - MD Magazine

Submitted by Anonymous (not verified) on Tue, 01/21/2025 - 14:39

FDA Approves Esketamine as First Monotherapy for Treatment-Resistant Depression  MD Magazine